论文部分内容阅读
本刊讯国家药品监督管理局日前发出通知 ,终止了１０余种研究中存在问题的药物品种的审评 ,并责成有关省、市药监部门对相关申报单位作出处理。这些被终止审评的药物品种分别是 :哈尔滨市天一天然药物研究所和黑龙江肇东华富药业有限责任公司共同申报的“尼美舒利分散片”和“
The State Department of Drug Administration recently issued a circular to terminate the study of more than 10 kinds of problems in the review of drug varieties, and instructed the provinces and municipalities Drug Administration departments to deal with the relevant declarations. These were discontinued review of drug varieties are: Harbin Tianyi Natural Medicine Institute and Zhaodong Huaifu Pharmaceutical Co., Ltd. jointly declared the “Nimesulide dispersible tablets” and "